InsidersTradesSigma
Browse the complete record of transactions filed by Henrik Stenqvist, 首席财务官. Director active across 2 companies, notably Swedish Orphan Biovitrum AB (publ). Cumulatively, 1 disclosures have been logged. History available since 24 October 2025. The latest transaction was filed on 24 October 2025 (Purchase). Regulator: FIN-FSA. The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 条申报中的 1 条
Henrik Stenqvist is the Chief Financial Officer of Swedish Orphan Biovitrum AB (publ), a biopharmaceutical company. He is responsible for financial management and the economic strategy of the company.